SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Dave Gore's Trades That Make Sense

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dave Gore who wrote (11099)8/10/2002 1:46:47 PM
From: Arthur Radley  Read Replies (1) of 16631
 
ALTH update:
1) ALTH reached another milestone this week. Phase III enrollment concluded earlier than projected...many that oncologist had no problems finding candidates for the trials. This now starts the clock for the 6 mos. follow-up collection of data and shortly after filing of the NDA.

2) ALTH has moved up on the Investor's Business Daily TA charts to a 97 on Relative Strength rating and continues with a A for accumulation.
You can count on your two hands the number of NASDAQ stocks that have a 97 RS rating, and for that matter that also an A for accumulation rating. But you can't find ANY biotech with this dual high TA rating.

3) ALTH continues to move back to the 52 week high stock price...well above the 50DMA....hard to find any biotech trading at the upper end of their trading range, but ALTH is within .35 cents of its 52 week high.

Subject 53192
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext